| Predicting clinical outcomes from large scale cancer genomic profiles with deep survival models S Yousefi, F Amrollahi, M Amgad, C Dong, JE Lewis, C Song, DA Gutman, ... Scientific reports 7 (1), 1-11, 2017 | 221 | 2017 |
| On the (uninteresting) dependence of the absorption and emission transition moments of coumarin 153 on solvent JE Lewis, M Maroncelli Chemical Physics Letters 282 (2), 197-203, 1998 | 198 | 1998 |
| Local density augmentation in supercritical solvents: electronic shifts of anthracene derivatives JE Lewis, R Biswas, AG Robinson, M Maroncelli The Journal of Physical Chemistry B 105 (16), 3306-3318, 2001 | 133 | 2001 |
| Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance JE Lewis, ML Kemp Nature communications 12 (1), 2700, 2021 | 105 | 2021 |
| Electronic spectral shifts, reorganization energies, and local density augmentation of Coumarin 153 in supercritical solvents R Biswas, JE Lewis, M Maroncelli Chemical physics letters 310 (5-6), 485-494, 1999 | 89 | 1999 |
| Personalized genome-scale metabolic models identify targets of redox metabolism in radiation-resistant tumors JE Lewis, TE Forshaw, DA Boothman, CM Furdui, ML Kemp Cell systems 12 (1), 68-81. e11, 2021 | 46 | 2021 |
| Peroxiredoxins in cancer and response to radiation therapies TE Forshaw, R Holmila, KJ Nelson, JE Lewis, ML Kemp, AW Tsang, ... Antioxidants 8 (1), 11, 2019 | 37 | 2019 |
| Genome-scale modeling of NADPH-driven β-lapachone sensitization in head and neck squamous cell carcinoma JE Lewis, F Costantini, J Mims, X Chen, CM Furdui, DA Boothman, ... Antioxidants & redox signaling 29 (10), 937-952, 2018 | 26 | 2018 |
| Targeting NAD+ metabolism to enhance radiation therapy responses JE Lewis, N Singh, RJ Holmila, BD Sumer, NS Williams, CM Furdui, ... Seminars in radiation oncology 29 (1), 6-15, 2019 | 24 | 2019 |
| MTHFD2 blockade enhances the efficacy of β-lapachone chemotherapy with ionizing radiation in head and neck squamous cell cancer K Shukla, N Singh, JE Lewis, AW Tsang, DA Boothman, ML Kemp, ... Frontiers in Oncology 10, 536377, 2020 | 16 | 2020 |
| Review of endometrial receptivity array: a personalized approach to embryo transfer and its clinical applications SC Rubin, M Abdulkadir, J Lewis, A Harutyunyan, R Hirani, CL Grimes Journal of Personalized Medicine 13 (5), 749, 2023 | 10 | 2023 |
| An integrative gene expression and mathematical flux balance analysis identifies targetable redox vulnerabilities in melanoma cells BB Paudel, JE Lewis, KN Hardeman, CE Hayford, CJ Robbins, ... Cancer research 80 (20), 4565-4577, 2020 | 10 | 2020 |
| Monkeypox outbreak in the age of COVID-19: a new global health emergency R Hirani, D Rashid, J Lewis, R Hosein-Woodley, A Issani Military Medical Research 9 (1), 55, 2022 | 7 | 2022 |
| An automated pipeline for differential cell counts on whole-slide bone marrow aspirate smears JE Lewis, CW Shebelut, BR Drumheller, X Zhang, N Shanmugam, ... Modern Pathology 36 (2), 100003, 2023 | 6 | 2023 |
| Redox integration of signaling and metabolism in a head and neck cancer model of radiation resistance using COSMRO Z Ji, J Moore, NO Devarie-Baez, J Lewis, H Wu, K Shukla, EIS Lopez, ... Frontiers in oncology 12, 946320, 2023 | 4 | 2023 |
| Psychopharmakotherapie von T Impulskontrollstörungen bei Kindern und Jugendlichen mit und ohne Intelligenzminderung F Häßler, J Buchmann, JM Fegert Nervenheilkunde 23 (06), 332-338, 2004 | 3 | 2004 |
| Digital assessment of peripheral blood and bone marrow aspirate smears JE Lewis, O Pozdnyakova International Journal of Laboratory Hematology 45, 50-58, 2023 | 1 | 2023 |
| Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry JE Lewis, LAD Cooper, DL Jaye, O Pozdnyakova Modern Pathology 37 (1), 100373, 2024 | | 2024 |
| Predicting Molecular Alterations from Blast Morphology of Acute Myeloid Leukemia Bone Marrow Aspirate Smears Using Machine Learning B Vadasz, J Gao, JE Lewis, DL Jaye, LAD Cooper Blood 142 (Supplement 1), 6005-6005, 2023 | | 2023 |
| One-year retrospective analysis of anti-FXa apixaban and rivaroxaban levels demonstrates utility for management decisions in various urgent and nonurgent clinical situations F Lucas, J Lewis, J Grandoni, KW Sylvester, TD Bernier, C Ting, R Sek, ... American Journal of Clinical Pathology 160 (6), 571-584, 2023 | | 2023 |
